Showing results (141-150 of 254) with videos related to

Sort By:
Pageof 26
Transplantation|March 24, 2023
Cardiovascular Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus and Reduced Calcineurin Inhibitor or Standard Triple Therapy: 24-month Post Hoc Analysis From TRANSFORM StudyClaudia Sommerer, Christophe Legendre, Franco Citterio, et al.
Kidney International|July 4, 2025
A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complicationsMichael Eder, Alexander Kainz, Haris Omic, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 7, 2022
Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation InterventionsAllison Tong, Rainer Oberbauer, Maria Irene Bellini, et al.
Circulation Research|April 7, 2021
Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in HemodialysisKatharina Dörr, Michael Kammer, Roman Reindl-Schwaighofer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 11, 2017
Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working groupUmberto Maggiore, Klemens Budde, Uwe Heemann, et al.
Proteomics. Clinical Applications|April 15, 2011
Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathyRaul Fechete, Andreas Heinzel, Paul Perco, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 28, 2007
Predictors of new-onset decline in kidney function in a general middle-european populationRudolf P Obermayr, Christian Temml, Maarten Knechtelsdorfer, et al.
Transplantation|April 30, 2003
Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trialRainer Oberbauer, Brian Hutchison, Josette Eris, et al.
Cardiovascular Diabetology|March 29, 2023
Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort studyMichael Kammer, Andreas Heinzel, Karin Hu, et al.
Plos One|August 4, 2012
Sirolimus induced phosphaturia is not caused by inhibition of renal apical sodium phosphate cotransportersMaria Haller, Stefan Amatschek, Julia Wilflingseder, et al.
Pageof 26